Gernot Beutel

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN).

Management of critically ill cancer patients. Expert consensus statement of the "Intensive Care for Hematology and Oncology Patients" (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN).

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 01, 2026

Impact of sampling side of peritoneal biopsies on peritoneal thickness and histopathological diagnosis-A quantitative histological study in body donors.

Impact of sampling side of peritoneal biopsies on peritoneal thickness and histopathological diagnosis-A quantitative histological study in body donors.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: April 13, 2026

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Journal: Oncology research

Published: October 01, 2025

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Journal: Oncoimmunology

Published: August 16, 2025

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Journal: Cancers

Published: August 14, 2025

Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Journal: Leukemia

Published: June 18, 2025

Effectiveness of venetoclax based therapy in t(11;14) multiple myeloma with extensive extramedullary disease: a case report.

Effectiveness of venetoclax based therapy in t(11;14) multiple myeloma with extensive extramedullary disease: a case report.

Journal: Annals of hematology

Published: April 20, 2025

Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10).

Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10).

Journal: Leukemia

Published: March 26, 2025

Randomization in phase II trials: No exemption based on sample size.

Randomization in phase II trials: No exemption based on sample size.

Journal: British journal of clinical pharmacology

Published: December 05, 2024

Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry.

Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry.

Journal: Annals of hematology

Published: November 06, 2024

Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study.

Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study.

Journal: Cancer medicine

Published: September 23, 2024

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.

Journal: The Lancet regional health. Europe

Published: July 19, 2024

Showing 1-12 of 99

Last Updated: 09/26/2026